<DOC>
	<DOCNO>NCT00975533</DOCNO>
	<brief_summary>This study aim analyze pre- post-operative clinical , hormonal biochemical change moderately obese type 2 diabetic patient sub-optimally control least 2 anti-diabetic agent . Study participant either receive implantation gastric contraction modulator conventional treatment insulin therapy .</brief_summary>
	<brief_title>Gastric Modulator ( TANTALUSÂ® System ) Versus Insulin Treatment Obese Type 2 Diabetic Patients - Randomized Control Trial</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Able provide write informed consent Adult patient age 18 60 year ( inclusive ) Male female Chinese ethnicity Type 2 diabetes mellitus disease duration great 2 less 10 year severe obesity , include BMI 25 27.5 kg/m central obesity define waist circumference great 90 cm woman great 95 men , BMI great 27.5 less 35 kg/m HbA1c great equal 7.5 % le 10 % despite treated maximum dose maximally tolerate dose 2 antidiabetic drug ( OAD ) good drug compliance On antiobesity drug On insulin treatment time recruitment On glitazone incretins ( dipeptidyl peptidase4 inhibitor glucagonslike peptide1 ) treatment On implantable device include cardiac pacing Anticipated MRI examination Fasting Cpeptide level le 0.5g/L Renal impairment ( define serum creatinine great 150mol/L and/or estimate glomerular filtration rate le 60 mL/min/1.73m ) Significant liver impairment ( ALT 3 time upper limit normal range ) Active malignant disease . Patients malignant disease diseasefree least 5 year eligible Active infection Active uncontrolled thyroid disease Childbearing age female patient without reliable contraceptive method Life expectancy le 12 month Administration another investigational drug procedure within 4 week screen Any medical illness condition judge investigator ineligible participate study Special population , e.g . prisoner , mentally disabled , investigator ' student employee</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>type 2 diabetes mellitus</keyword>
	<keyword>obesity</keyword>
</DOC>